18 Jan 2024 | 04:00 PM GMT
Past Meeting

Do Accelerators Work to Nurture Innovation?

Participants:

Jochen Hurlebaus President & OwnerAluna Healthcare Consulting GmbHInvestor & Accelerators
Investor & Accelerators
Jochen Hurlebaus
President & OwnerAluna Healthcare Consulting GmbH
Sophie Park Managing DirectorBayer G4ALife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Sophie Park
Managing DirectorBayer G4A
Xenia Riasol Cercos Sponsored Programs Strategy ManagerHLTHOther
Other
Xenia Riasol Cercos
Sponsored Programs Strategy ManagerHLTH
Aahuti Rai Health Innovation Leader & Venture PartnerFour Points HealthHealth Tech & Solutions
Health Tech & Solutions
Aahuti Rai
Health Innovation Leader & Venture PartnerFour Points Health
Hannes Toivanen Lead, Global Digital Ecosystems EngamentsTakedaLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Hannes Toivanen
Lead, Global Digital Ecosystems EngamentsTakeda
Matt Norton VP of Marketing & Commercial DevelopmentS3 Connected HealthProfessional Services
Professional Services
Matt Norton
VP of Marketing & Commercial DevelopmentS3 Connected Health
Shwen Gwee Member of the Advisory BoardNew Enterprise Ventures
Shwen Gwee
Member of the Advisory BoardNew Enterprise Ventures
Susanne Gruber Strategic Advisor, Interim ExecutiveIgnited VisionProfessional Services
Professional Services
Susanne Gruber
Strategic Advisor, Interim ExecutiveIgnited Vision
Timothy Graham Director, Digital Data and TechnologyGSKLife Sciences, Pharma & Biotech
Life Sciences, Pharma & Biotech
Timothy Graham
Director, Digital Data and TechnologyGSK

About this Meeting

Accelerators play a crucial role in nurturing innovation in pharma by bringing together diverse and innovative stakeholders to create a collaborative ecosystem that fosters the exchange of ideas, expertise, and best practices most conducive to breakthrough discoveries and advancements.  
 
Accelerators are not a one-size-fits-all solution for disruptors in the digital health space.  The value of these programmes depends on factors such as mentorship quality, network relevance, and alignment with company growth needs. Furthermore, an accelerator’s success in this space relies on its ability to adapt to the ever-changing technology needs of pharma and its customers, staying ahead of emerging trends and technologies.   

Join this discussion to collectively determine how accelerators can be the best fit for innovation:   

  • What are the key benefits and potential drawbacks of participating in acceleration programmes for startups?  
  • What factors should startups consider to ensure that an acceleration programme aligns with their specific needs, goals, and values?  
  • What can pharma do to ensure that acceleration programmes benefit both entities equally? Where can pharma let accelerators bring the greatest value to digital health?  
We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

About Us

HLTH Inc. is a dynamic community delivering unique value to the healthcare industry through a mix of unparalleled global events, inspirational content, and impact-driven initiatives.

Hyve Logo

USA Event Dates

2026 | HLTH: Nov 15 – 18 | Las Vegas | Register | Sponsor
2027 | ViVE: Mar 14 – 17 | Nashville | Be First to Know | Sponsor
2027 | HLTH: Oct 17 – 20 | Las Vegas, NV

Europe Event Dates

2027 | HLTH Europe: Jun 21 – 24 | Amsterdam | Sponsor
2028 | HLTH Europe: Jun 19 – 22 | Amsterdam

Important Notice on Hotel Scams

Any communication that claims to represent HLTH or any third party offering discounted hotel rooms or attendee lists is NOT AFFILIATED with HLTH and should be considered fraudulent. Please book your accommodations only through HLTH’s official channels to ensure authenticity and security.